550 related articles for article (PubMed ID: 29344951)
21. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
[TBL] [Abstract][Full Text] [Related]
22. Molecular approaches for classifying endometrial carcinoma.
Piulats JM; Guerra E; Gil-Martín M; Roman-Canal B; Gatius S; Sanz-Pamplona R; Velasco A; Vidal A; Matias-Guiu X
Gynecol Oncol; 2017 Apr; 145(1):200-207. PubMed ID: 28040204
[TBL] [Abstract][Full Text] [Related]
23. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
24. New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care.
Talhouk A; McAlpine JN
Gynecol Oncol Res Pract; 2016; 3():14. PubMed ID: 27999680
[TBL] [Abstract][Full Text] [Related]
25. Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.
Britton H; Huang L; Lum A; Leung S; Shum K; Kale M; Burleigh A; Senz J; Yang W; McConechy M; Kommoss S; Brucker S; Talhouk A; Gilks CB; McAlpine JN
Gynecol Oncol; 2019 Jun; 153(3):487-495. PubMed ID: 30922603
[TBL] [Abstract][Full Text] [Related]
26. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors.
Ritterhouse LL; Howitt BE
Surg Pathol Clin; 2016 Sep; 9(3):405-26. PubMed ID: 27523969
[TBL] [Abstract][Full Text] [Related]
27. The molecular basis of breast cancer pathological phenotypes.
Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
[TBL] [Abstract][Full Text] [Related]
28. Ethical considerations for modern molecular pathology.
Vos S; van Diest PJ; Ausems MG; van Dijk MR; de Leng WW; Bredenoord AL
J Pathol; 2018 Dec; 246(4):405-414. PubMed ID: 30125358
[TBL] [Abstract][Full Text] [Related]
29. Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer.
Murali R; Delair DF; Bean SM; Abu-Rustum NR; Soslow RA
J Natl Compr Canc Netw; 2018 Feb; 16(2):201-209. PubMed ID: 29439179
[TBL] [Abstract][Full Text] [Related]
30. TCGA Classification of Endometrial Cancer: the Place of Carcinosarcoma.
Travaglino A; Raffone A; Gencarelli A; Mollo A; Guida M; Insabato L; Santoro A; Zannoni GF; Zullo F
Pathol Oncol Res; 2020 Oct; 26(4):2067-2073. PubMed ID: 32472441
[TBL] [Abstract][Full Text] [Related]
31. Endometrial Cancer: An Update on Prognostic Pathologic Features and Clinically Relevant Biomarkers.
Li JJX; Ip PPC
Surg Pathol Clin; 2022 Jun; 15(2):277-299. PubMed ID: 35715162
[TBL] [Abstract][Full Text] [Related]
32. Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours.
Cochrane DR; Campbell KR; Greening K; Ho GC; Hopkins J; Bui M; Douglas JM; Sharlandjieva V; Munzur AD; Lai D; DeGrood M; Gibbard EW; Leung S; Boyd N; Cheng AS; Chow C; Lim JL; Farnell DA; Kommoss S; Kommoss F; Roth A; Hoang L; McAlpine JN; Shah SP; Huntsman DG
J Pathol; 2020 Oct; 252(2):201-214. PubMed ID: 32686114
[TBL] [Abstract][Full Text] [Related]
33. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
[TBL] [Abstract][Full Text] [Related]
34. Reclassifying endometrial carcinomas with a combined morphological and molecular approach.
Carlson J; McCluggage WG
Curr Opin Oncol; 2019 Sep; 31(5):411-419. PubMed ID: 31261170
[TBL] [Abstract][Full Text] [Related]
35. Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis.
Huvila J; Pors J; Thompson EF; Gilks CB
J Pathol; 2021 Apr; 253(4):355-365. PubMed ID: 33368243
[TBL] [Abstract][Full Text] [Related]
36. Integration of Clinical and Molecular Features into Prediction Models for Outcomes in Endometrial Cancer.
Miller MD; Devor EJ
Clin Obstet Gynecol; 2020 Mar; 63(1):40-47. PubMed ID: 31725417
[TBL] [Abstract][Full Text] [Related]
37. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
38. Incorporation of molecular characteristics into endometrial cancer management.
Vermij L; Smit V; Nout R; Bosse T
Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
[TBL] [Abstract][Full Text] [Related]
39. Update in the molecular classification of endometrial carcinoma.
Léon-Castillo A
Int J Gynecol Cancer; 2023 Mar; 33(3):333-342. PubMed ID: 36878561
[TBL] [Abstract][Full Text] [Related]
40. Moving into the modern era of molecular classification for endometrial cancer.
Dagher C; Liu YL; Mueller JJ; Weigelt B
J Surg Oncol; 2024 Jan; 129(1):120-125. PubMed ID: 38100711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
